Biotin-beta-Amyloid (25-35) – 1 mg

Overview

The Biotin-beta-Amyloid (25-35) is a biotinylated peptide that offers a valuable tool for researchers studying Alzheimer’s disease and related neurodegenerative conditions. This specific peptide, encompassing amino acids 25 to 35 of the full-length ß-amyloid, maintains essential characteristics such as its amphiphilic nature and ability to aggregate. These properties make it an ideal candidate for examining the conformational changes that occur in the development of Alzheimer’s, allowing you to gain insights into the disease’s pathology.

Key Features

• Biotinylated at the C-terminus for easy detection.
• Retains aggregative and amphiphilic properties similar to full-length ß-amyloid.
• Serves as a model system in Alzheimer’s disease research.
• Exhibits neurotrophic and neurotoxic properties.
• 1 mg of high-purity peptide for experimental use.

Specifications

FAQ

What makes Biotin-beta-Amyloid (25-35) valuable in research?

This peptide’s ability to mimic the properties of full-length ß-amyloid allows researchers to study the aggregation processes and neurotoxic effects associated with Alzheimer’s disease, providing critical insights for potential therapeutic strategies.

How can I utilize this peptide in experiments?

You can use Biotin-beta-Amyloid (25-35) in various assays to observe its aggregation behavior or to evaluate its effects on neuronal cells, which can help you understand its role in Alzheimer’s pathology.

Is this peptide suitable for labeling applications?

Yes, the biotinylation at the C-terminus facilitates the use of this peptide in detection assays by allowing easy binding to streptavidin-coated surfaces, making it a versatile option for labeling applications.

Explore other peptides in our catalog for comprehensive research solutions. For enhanced experimentation, consider pairing with PKG Substrate or Autocamtide-2 for streamlined protein interactions.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled